Invention Grant
- Patent Title: Methods of using factor B inhibitors
-
Application No.: US17376483Application Date: 2021-07-15
-
Publication No.: US11951101B2Publication Date: 2024-04-09
- Inventor: Irina Baltcheva , Peter End , Julie Marie-Pomme Gabrielle Milojevic
- Applicant: Novartis AG
- Applicant Address: CH Basel
- Assignee: Novartis AG
- Current Assignee: Novartis AG
- Current Assignee Address: CH Basel
- Agent Timothy P. O'Dea
- Main IPC: A61K31/454
- IPC: A61K31/454 ; A61K9/00 ; A61P7/06
Abstract:
Described herein are methods of treating paroxysmal nocturnal hemoglobinuria (PNH) with the Factor B inhibitor LNP023 or a pharmaceutically acceptable salt thereof, e.g. LNP023 hydrochloride.
Public/Granted literature
- US20220016103A1 METHODS OF USING FACTOR B INHIBITORS Public/Granted day:2022-01-20
Information query
IPC分类:
